Handling cytotoxic drugs
Burton, S.M.
Professional Nurse 3(12): 496-497
1988
ISSN/ISBN: 0266-8130 PMID: 3413147 Document Number: 314394
Document emailed within 1 workday
Related Documents
Fennelly, J.J. 1971: Drugs and their abuse no. V--misuse of cytotoxic drugs Journal of the Irish Medical Association 64(416): 383-384Lewis, B.J. 1970: Prescribing and handling drugs in hospital Nursing Mirror and Midwives Journal 131(16): 24-27
Fischer, P. 1971: Handling drugs with gold content Pharmazeutische Praxis 10: 233
Neiger, R. 1996: Guidelines for the handling of antineoplastic drugs Schweizer Archiv für Tierheilkunde 138(8): 383-386
Ng, L.M.; Jaffe, N. 1970: Possible hazards of handling antineoplastic drugs Pediatrics 46(4): 648-649
Gallelli, J.F. 1982: Evaluating the potential hazard of handling antineoplastic drugs American Journal of Hospital Pharmacy 39(11): 1877
Valanis, B.; Shortridge, L. 1987: Self protective practices of nurses handling antineoplastic drugs Oncology Nursing Forum 14(3): 23-27
Amigo Tadín, M. 2005: Drugs, a current problem: difficulties in handling drug addictions Revista de Enfermeria 28(12): 9-10
Fujino, N.; Tada, H. 1981: Monitoring, examination, special equipment, handling of drugs and the keypoints in neonatal emergencies Josanpu Zasshi 35(4): 271-277
Wolff, K.; Shanab, M.A.; Sanderson, M.J.; Hay, A.W. 1990: Screening for drugs of abuse: effect of heat-treating urine for safe handling of samples Clinical Chemistry 36(6): 908-910
Medková, J. 1991: Hygienic examination and follow-up of occupational risks of handling cytostatic drugs at an oncology unit Acta Universitatis Palackianae Olomucensis Facultatis Medicae 129: 241-253
Lee, J. 2011: Total recall. Providers are taking the lead in revamping system for handling questionable drugs and medical devices Modern Healthcare 41(32): 28 30
Selvey, D. 1985: Cytotoxic drugs: cabinet security Nursing Times 81(47): 39
Jaskiewicz, K.; Voigt, M.D.; Koopovitz, A. 1992: Hepatic sinusoidal fibrosis associated with the use of cytotoxic drugs South African Medical Journal 81(12): 626-627
Stuart, M.; Frogge, M.H. 1982: Sequence of administering vesicant cytotoxic drugs Oncology Nursing Forum 9(1): 53-54
Waytz, P. 1983: Cytotoxic drugs in the treatment of rheumatic diseases Minnesota Medicine 66(7): 429
Oommen, R.; Jose, C.C.; Vishwanathan, F.; Roul, R.K.; Singh, A.D. 1991: Ovarian and testicular damage by cytotoxic drugs Indian Journal of Cancer 28(3): 119-123
Wynter, M.P.; Russell, S.T.; Tisdale, M.J. 2004: Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs In Vivo 18(5): 543-547
Rahman, A.; Dusre, L.; Forst, D.; Thierry, A.; Roh, J.K.; Greenspan, A.; Treat, J. 1990: Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs Progress in Clinical and Biological Research 343: 281-304
Rubaltelli, F.F.; Mittiga, S.; Solito, P. 1982: Growth and development of children born to mothers treated with cytotoxic drugs during pregnancy Helvetica Paediatrica Acta 37(6): 599-601